Research ArticleClinical Investigations
First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination
Weixing Wan, Ning Guo, Donghui Pan, Chunjing Yu, Yuan Weng, Shineng Luo, Hong Ding, Yuping Xu, Lizhen Wang, Lixin Lang, Qingguo Xie, Min Yang and Xiaoyuan Chen
Journal of Nuclear Medicine May 2013, 54 (5) 691-698; DOI: https://doi.org/10.2967/jnumed.112.113563
Weixing Wan
1Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China
2Department of Nuclear Medicine, Wuxi No. 4 People’s Hospital, Wuxi, China
Ning Guo
3Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland
4Department of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, Hubei, China; and
5Center for Molecular Imaging and Translational Medicine, Xiamen University, Xiamen, Fujian, China
Donghui Pan
1Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China
Chunjing Yu
2Department of Nuclear Medicine, Wuxi No. 4 People’s Hospital, Wuxi, China
Yuan Weng
2Department of Nuclear Medicine, Wuxi No. 4 People’s Hospital, Wuxi, China
Shineng Luo
1Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China
Hong Ding
1Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China
Yuping Xu
1Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China
Lizhen Wang
1Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China
Lixin Lang
3Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland
Qingguo Xie
4Department of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, Hubei, China; and
Min Yang
1Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China
Xiaoyuan Chen
3Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 5
May 1, 2013
First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination
Weixing Wan, Ning Guo, Donghui Pan, Chunjing Yu, Yuan Weng, Shineng Luo, Hong Ding, Yuping Xu, Lizhen Wang, Lixin Lang, Qingguo Xie, Min Yang, Xiaoyuan Chen
Journal of Nuclear Medicine May 2013, 54 (5) 691-698; DOI: 10.2967/jnumed.112.113563
First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination
Weixing Wan, Ning Guo, Donghui Pan, Chunjing Yu, Yuan Weng, Shineng Luo, Hong Ding, Yuping Xu, Lizhen Wang, Lixin Lang, Qingguo Xie, Min Yang, Xiaoyuan Chen
Journal of Nuclear Medicine May 2013, 54 (5) 691-698; DOI: 10.2967/jnumed.112.113563
Jump to section
Related Articles
Cited By...
- 18F-Alfatide II PET/CT for Identification of Breast Cancer: A Preliminary Clinical Study
- 18F-AlF-Labeled Biomolecule Conjugates as Imaging Pharmaceuticals
- Recent Advances in 18F Radiochemistry: A Focus on B-18F, Si-18F, Al-18F, and C-18F Radiofluorination via Spirocyclic Iodonium Ylides
- In Vivo Imaging of the Programmed Death Ligand 1 by 18F PET
- Can an 18F-ALF-NOTA-PRGD2 PET/CT Scan Predict Treatment Sensitivity to Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
- RGD PET: From Lesion Detection to Therapy Response Monitoring
- PET-Based Human Dosimetry of the Dimeric {alpha}v{beta}3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis
- Harnessing the Power of Molecular Imaging for Precision Medicine
- 68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer
- In Vivo Evaluation of 18F-SiFAlin-Modified TATE: A Potential Challenge for 68Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET
- 18F-FPRGD2 PET/CT Imaging of Integrin {alpha}v{beta}3 in Renal Carcinomas: Correlation with Histopathology
- Effect of Chelate Type and Radioisotope on the Imaging Efficacy of 4 Fibrin-Specific PET Probes
- Al18F Labeling of Affibody Molecules
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
- Al18F: A New Standard for Radiofluorination